Cargando…
Should we rely on trials with disease- rather than patient-oriented endpoints?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924659/ https://www.ncbi.nlm.nih.gov/pubmed/28608246 http://dx.doi.org/10.1007/s00134-017-4859-0 |
| _version_ | 1783318578119835648 |
|---|---|
| author | de Grooth, Harm-Jan Parienti, Jean-Jacques Oudemans-van Straaten, Heleen M. |
| author_facet | de Grooth, Harm-Jan Parienti, Jean-Jacques Oudemans-van Straaten, Heleen M. |
| author_sort | de Grooth, Harm-Jan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5924659 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59246592018-05-01 Should we rely on trials with disease- rather than patient-oriented endpoints? de Grooth, Harm-Jan Parienti, Jean-Jacques Oudemans-van Straaten, Heleen M. Intensive Care Med What's New in Intensive Care Springer Berlin Heidelberg 2017-06-12 2018 /pmc/articles/PMC5924659/ /pubmed/28608246 http://dx.doi.org/10.1007/s00134-017-4859-0 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | What's New in Intensive Care de Grooth, Harm-Jan Parienti, Jean-Jacques Oudemans-van Straaten, Heleen M. Should we rely on trials with disease- rather than patient-oriented endpoints? |
| title | Should we rely on trials with disease- rather than patient-oriented endpoints? |
| title_full | Should we rely on trials with disease- rather than patient-oriented endpoints? |
| title_fullStr | Should we rely on trials with disease- rather than patient-oriented endpoints? |
| title_full_unstemmed | Should we rely on trials with disease- rather than patient-oriented endpoints? |
| title_short | Should we rely on trials with disease- rather than patient-oriented endpoints? |
| title_sort | should we rely on trials with disease- rather than patient-oriented endpoints? |
| topic | What's New in Intensive Care |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924659/ https://www.ncbi.nlm.nih.gov/pubmed/28608246 http://dx.doi.org/10.1007/s00134-017-4859-0 |
| work_keys_str_mv | AT degroothharmjan shouldwerelyontrialswithdiseaseratherthanpatientorientedendpoints AT parientijeanjacques shouldwerelyontrialswithdiseaseratherthanpatientorientedendpoints AT oudemansvanstraatenheleenm shouldwerelyontrialswithdiseaseratherthanpatientorientedendpoints |